Enovis Reports Third-Quarter Revenue of $558.73 Million and EPS of $0.06
Enovis said third-quarter sales rose 1.8% year over year. Growth from existing businesses across both segments more than offset the Dr. Comfort divestiture and unfavorable currency translation; earnings improved from a year-earlier loss, primarily reflecting the absence of prior-year goodwill impairment.
Enovis’ third-quarter sales rose 1.8% year over year as growth from existing businesses across both segments more than offset the Dr. Comfort divestiture and unfavorable currency translation. Earnings improved from a prior-year loss, primarily reflecting the absence of the prior-year goodwill impai…